Standout Papers

Mdm2 promotes the rapid degradation of p53 1991 2026 2002 2014 3.7k
  1. Mdm2 promotes the rapid degradation of p53 (1997)
    Ygal Haupt, Ruth Maya et al. Nature
  2. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 (1991)
    Elisheva Yonish-Rouach, Joseph Lotem et al. Nature
  3. The first 30 years of p53: growing ever more complex (2009)
    Arnold J. Levine, Moshe Oren Nature reviews. Cancer
  4. mdm2 expression is induced by wild type p53 activity. (1993)
    Yaacov Barak, Rebecca Haffner et al. The EMBO Journal
  5. Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis (2007)
    Eti Meiri, Yael Spector et al. Molecular Cell
  6. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. (1988)
    Cathy A. Finlay, Philip W. Hinds et al. Molecular and Cellular Biology
  7. Decision making by p53: life, death and cancer (2003)
    Moshe Oren Cell Death and Differentiation
  8. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis (2011)
    Noa Rivlin, Ran Brosh et al. Genes & Cancer
  9. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs (1998)
    Martina Müller, Sylvia Wilder et al. The Journal of Experimental Medicine
  10. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 (1990)
    Dan Michalovitz, Orna Halevy et al. Cell
  11. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells (1984)
    Daniel Eliyahu, Avraham Raz et al. Nature
  12. The p53–Mdm2 module and the ubiquitin system (2002)
    Dan Michael, Moshe Oren Seminars in Cancer Biology
  13. Wild-type p53 can inhibit oncogene-mediated focus formation. (1989)
    Daniel Eliyahu, Dan Michalovitz et al. Proceedings of the National Academy of Sciences
  14. Mutant p53 Gain-of-Function in Cancer (2009)
    Moshe Oren, Varda Rotter Cold Spring Harbor Perspectives in Biology
  15. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage (2001)
    Ruth Maya, Moshe Balass et al. Genes & Development
  16. Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer (2013)
    Tomer Cooks, Ioannis S. Pateras et al. Cancer Cell
  17. Drugging p53 in cancer: one protein, many targets (2022)
    Ori Hassin, Moshe Oren Nature Reviews Drug Discovery

Immediate Impact

25 by Nobel laureates 190 from Science/Nature 335 standout
Sub-graph 1 of 9

Citing Papers

Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Hallmarks of Cancer: The Next Generation
2011 Standout
22 intermediate papers

Works of Moshe Oren being referenced

p53 and apoptosis
1998
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
and 34 more

Author Peers

Author Last Decade Papers Cites
Moshe Oren 34533 28528 7097 9746 323 48.3k
David P. Lane 37043 31996 6900 8635 606 57.0k
Wafik S. El‐Deiry 32596 23024 4645 9235 569 46.2k
Karen H. Vousden 34167 24148 4687 12175 239 48.4k
Charles J. Sherr 38985 30272 3307 6856 270 57.5k
Michael B. Kastan 30153 18219 3000 8218 153 38.5k
Scott W. Lowe 49438 22670 3934 16688 324 68.3k
David Beach 34200 20131 2818 5250 241 46.9k
Carol Prives 25364 20763 4293 6107 216 33.3k
Kornélia Polyák 29875 26258 2154 14562 198 48.9k
Jiří Bártek 40971 22942 1625 9316 378 52.8k

All Works

Loading papers...

Rankless by CCL
2026